Research Paper Volume 16, Issue 11 pp 10016—10032

Landscape analysis of alternative splicing in kidney renal clear cell carcinoma and their clinical significance

Songtao Cheng1, , Zili Zhou2, , Jiannan Liu1, , Jun Li1, , Yu Wang1, , Jiantao Xiao3, , Yongwen Luo3, ,

  • 1 Department of Urology, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
  • 2 Department of Gastrointestinal Surgery, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China
  • 3 Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China

Received: October 30, 2023       Accepted: April 25, 2024       Published: June 10, 2024      

https://doi.org/10.18632/aging.205915
How to Cite

Copyright: © 2024 Cheng et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

A growing number of studies reveal that alternative splicing (AS) is associated with tumorigenesis, progression, and metastasis. Systematic analysis of alternative splicing signatures in renal cancer is lacking. In our study, we investigated the AS landscape of kidney renal clear cell carcinoma (KIRC) and identified AS predictive model to improve the prognostic prediction of KIRC. We obtained clinical data and gene expression profiles of KIRC patients from the TCGA database to evaluate AS events. The calculation results for seven types of AS events indicated that 46276 AS events from 10577 genes were identified. Next, we applied Cox regression analysis to identify 5864 prognostic-associated AS events. We used the Metascape database to verify the potential pathways of prognostic-associated AS. Moreover, we constructed KIRC prediction systems with prognostic-associated AS events by the LASSO Cox regression model. AUCs demonstrated that these prediction systems had excellent prognostic accuracy simultaneously. We identified 34 prognostic associated splicing factors (SFs) and constructed homologous regulatory networks. Furthermore, in vitro experiments were performed to validate the favorable effect of SFs FMR1 in KIRC. In conclusion, we overviewed AS events in KIRC and identified AS-based prognostic models to assist the survival prediction of KIRC patients. Our study may provide a novel predictive signature to improve the prognostic prediction of KIRC, which might facilitate KIRC patient counseling and individualized management.

Abbreviations

AS: Alternative Splicing; KIRC: Kidney Renal Clear Cell Carcinoma; SFs: Splicing Factors; RCC: Renal Cell Carcinoma; TCGA: The Cancer Genome Atlas; PSI: Percent Spliced In; ES: Exon Skip; AP: Alternate Promoter; AT: Alternate Terminator; AA: Alternate Acceptor site; AD: Alternate Donor site; RI: Retained Intron; ME: Mutually Exclusive Exons; OS: Overall Survival; PPI: Protein-Protein Interaction; GO: Gene Ontology; LASSO: Least Absolute Shrinkage and Selection Operator; ROC: Receiver Operating Characteristic.